Electromed Capital Expenditures Over Time
| ELMD Stock | USD 24.80 0.07 0.28% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Electromed Performance and Electromed Correlation. Electromed |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.158 | Earnings Share 0.75 | Revenue Per Share | Quarterly Revenue Growth 0.187 | Return On Assets |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Capital Expenditures Analysis
Compare Electromed and related stocks such as Neuropace, Orthopediatrics Corp, and SurModics Capital Expenditures Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPCE | 468 K | 468 K | 468 K | 468 K | 468 K | 468 K | 468 K | 468 K | 468 K | 468 K | 62 K | 384 K | 603 K | 173 K | 306 K | 266.1 K |
| KIDS | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 2.3 M | 4.8 M | 6.5 M | 5.5 M | 12.1 M | 11.3 M | 16 M | 10 M | 19 M | 14.3 M | 10.5 M |
| SRDX | 800 K | 763 K | 1.9 M | 2.3 M | 1.9 M | 8.2 M | 6.4 M | 14.1 M | 6.7 M | 3.7 M | 6.3 M | 3.4 M | 2.9 M | 3.5 M | 3.1 M | 5.6 M |
| FNA | 18 M | 18 M | 18 M | 18 M | 18 M | 18 M | 18 M | 18 M | 18 M | 18 M | 10.8 M | 21.3 M | 43.1 M | 28 M | 16.9 M | 25.3 M |
| LIVN | 300 K | 18 M | 14.3 M | 19.1 M | 6.7 M | 16.1 M | 37.2 M | 34.1 M | 38 M | 28 M | 35 M | 25.5 M | 26.5 M | 35 M | 47.1 M | 49.5 M |
| LUNG | 1 K | 1 K | 1 K | 1 K | 63.1 K | 164.5 K | 27.2 K | 27.2 K | 316 K | 720 K | 911 K | 3.7 M | 1.3 M | 807 K | 1.4 M | 868.4 K |
| IRMD | 161.6 K | 161.6 K | 161.6 K | 191.8 K | 606.3 K | 314.8 K | 1.5 M | 824.8 K | 264.7 K | 485.8 K | 636.7 K | 741.8 K | 1.9 M | 8 M | 8 M | 8.4 M |
| OFIX | 600 K | 25.8 M | 28.8 M | 30.2 M | 18.5 M | 27.9 M | 18.3 M | 16.9 M | 15.3 M | 20.5 M | 17.1 M | 19.6 M | 23.2 M | 62 M | 34.9 M | 18 M |
| ITGR | 9 M | 22.5 M | 41.1 M | 18.6 M | 24.8 M | 44.6 M | 58.6 M | 47.3 M | 44.9 M | 48.2 M | 51.4 M | 53.5 M | 74.7 M | 119.9 M | 105.6 M | 110.9 M |
| AORT | 600 K | 2.5 M | 3.1 M | 4.3 M | 5.3 M | 4.1 M | 7.4 M | 7 M | 5.8 M | 8.1 M | 7.3 M | 13.1 M | 10.7 M | 7.4 M | 11.2 M | 11.7 M |
| AXGN | 200 K | 89.5 K | 127.3 K | 244 K | 594 K | 555.5 K | 1.2 M | 1.3 M | 6.6 M | 121.6 M | 22.6 M | 28.4 M | 21.3 M | 14.9 M | 4.5 M | 7.1 M |
| CNMD | 3.3 M | 21.7 M | 21.5 M | 18.4 M | 15.4 M | 15 M | 14.8 M | 12.8 M | 16.5 M | 20.1 M | 13 M | 14.9 M | 21.8 M | 19 M | 13.1 M | 17.5 M |
| SGHT | 570 K | 570 K | 570 K | 570 K | 570 K | 570 K | 570 K | 570 K | 570 K | 672 K | 953 K | 813 K | 970 K | 791 K | 385 K | 589 K |
Electromed and related stocks such as Neuropace, Orthopediatrics Corp, and SurModics Capital Expenditures description
Capital Expenditures are funds used by Electromed to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Electromed operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.My Equities
My Current Equities and Potential Positions
| Electromed | ELMD |
| Classification | Medical Equipment |
| Location | Minnesota; U.S.A |
| Exchange | NYSE MKT Exchange |
USD 24.8
Check out Electromed Performance and Electromed Correlation. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Electromed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.